USPTO serial 78448445
ANCELEX
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMOTHE, LESLEY
- Law office
- TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANCELEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alisa C. Simmons
ALISA C SIMMONS MARSHALL GERSTEIN & BORUN LLP233 S WACKER DR STE 6300SEARS TWRCHICAGO, IL 60606-6357Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays, screening kits, devices, and equipment for scientific analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceutical preparations for treatment of inflammation, infectious diseases, cancer, lysosomal storage diseases, mucopolysaccharidoses, enzyme disorders, infections, respiratory diseases, pain, fever, cough, colds, skin diseases, and allergies; pharmaceutical preparations for treatment of endocrine, rheumatic, collagen, dermatologic, opthalmic, hematologic, euplastic, neoplastic, cardiovascular, gastrointestinal, neurological, metabolic, and genetic diseases and disorders; enzymes for use in disease treatment; enzymes for use in the treatment of fungal infections; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of medical conditions; assays, screening kits, devices, and equipment for medical anaylsis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for medical purposes; | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 29, 2004 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Nov 28, 2004 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Nov 28, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2004 | PAPER RECEIVED | — | |
| Jul 19, 2004 | NWAP | NEW APPLICATION ENTERED | — |